Radiation oncology research and clinical trial results to be featured at ASTRO’s Annual Meeting

The American Society for Radiation Oncology (ASTRO) announced today the press program for its 2020 Annual Meeting, which will feature studies on cancer treatment advances and discussions of topical issues including COVID-19. Researchers will present their findings via live webcasts on October 26 and 27. Register for press access at www.astro.org/annnualmeetingpress.

Read more

Rutgers Cancer Institute of New Jersey Awarded $1.6M for Rutgers Youth Enjoy Science (RUYES) Program for Underrepresented Youth and Educators

The Rutgers Youth Enjoy Science (RUYES) program, funded by the National Cancer Institute, will engage underrepresented minority undergraduate and high school students in cutting-edge cancer research, curriculum support, and professional development activities.

Read more

MD Anderson and Taiho Pharmaceutical announce collaboration to accelerate development of novel therapies for brain metastasis and other unmet medical needs

The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with brain metastases and those with cancers refractory to available therapies.

Read more

“Multitasking” AI Tool Extracts Cancer Data in Record Time

Digital cancer registries collect, manage, and store data on cancer patients to help identify trends in diagnoses and treatment. However, cancer pathology reports are complex. To better leverage data, scientists developed an artificial intelligence-based natural language processing tool to help extract information from textual pathology reports.

Read more

HDAC6 Can Control Tumor Growth and Halt Metastasis in Triple-Negative Breast Cancer

Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the journal Cancer Research by investigators at the GW Cancer Center.

Read more

Britta Will, Ph.D., Wins Pershing Square Sohn Prize for Cancer Research

Britta Will, Ph.D., assistant professor of medicine and of cell biology at Albert Einstein College of Medicine, has won a 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research. Dr. Will is one of seven New York City area-based scientists to receive the prestigious award, which provides $600,000 over three years for innovative basic science cancer research.

Read more

Brain Cancer: UVA IDs Gene Responsible for Deadly Glioblastoma

The discovery of the oncogene responsible for glioblastoma could be the brain tumor’s Achilles’ heel, one researcher says.

Read more